Reply from Meds Management:
Dear Mr Cahm,
Thank you for your e-mail about FreeStyle.
In response to your two questions I can confirm that:
1) Dorset CCG plans to commission FreeStyle Libre sensors in line with the recently published NHS England criteria for the allocated number of patients with Type 1 diabetes
2) The commissioning statement will be updated to reflect the agreed Amber status. Patients will be initiated and then monitored by secondary care for 6 months, in line with NHS guidance, and when appropriate will be transferred to primary care for continued prescribing.